Biotech highlight: SCYNEXIS (SCYX)
Back to back announcements of good news.
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
scynexis.com/news-media/press-releases/detail/313/scynexis-announces-3-million-national-institutes-of-health
scynexis.com/news-media/press-releases/detail/314/scynexis-announces-fda-approval-of-second-indication-for
(NOTE: NOT ADVICE IN ANYWAY!! JUST FOOD FOR THOUGHT AND DISCUSSION!!)
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
scynexis.com/news-media/press-releases/detail/313/scynexis-announces-3-million-national-institutes-of-health
scynexis.com/news-media/press-releases/detail/314/scynexis-announces-fda-approval-of-second-indication-for
(NOTE: NOT ADVICE IN ANYWAY!! JUST FOOD FOR THOUGHT AND DISCUSSION!!)
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.